These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33505917)

  • 1. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
    Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
    Front Oncol; 2020; 10():603671. PubMed ID: 33505917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic lymphoma kinase fusion protein expression is associated with a favorable prognosis in resected invasive mucinous lung adenocarcinoma: A retrospective study from two Chinese tertiary hospitals.
    Wang J; Wei P; Liu J; Su P; Xing A; Jing H; Hao J
    J Cancer Res Ther; 2022 Apr; 18(2):445-451. PubMed ID: 35645113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.
    Xu M; Hao Y; Zhou H; Shi Z; Si J; Song Z
    Med Oncol; 2023 Jun; 40(7):198. PubMed ID: 37294384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
    Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
    J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors.
    Wang T; Yang Y; Liu X; Deng J; Wu J; Hou L; Wu C; She Y; Sun X; Xie D; Chen C
    Korean J Radiol; 2021 Apr; 22(4):652-662. PubMed ID: 33236544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
    Ueda D; Ito M; Tsutani Y; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Aguado C; Kushitani K; Miyata Y; Arihiro K; Molina-Vila MA; Rosell R; Takeshima Y; Okada M
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3709-3718. PubMed ID: 33796913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
    Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
    Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
    Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.
    Zhang Y; Sun Y; Pan Y; Li C; Shen L; Li Y; Luo X; Ye T; Wang R; Hu H; Li H; Wang L; Pao W; Chen H
    Clin Cancer Res; 2012 Apr; 18(7):1947-53. PubMed ID: 22317764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
    Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling.
    Yang SR; Chang JC; Leduc C; Tan KS; Dogan S; Benayed R; Borsu L; Offin M; Drilon A; Travis WD; Arcila ME; Ladanyi M; Rekhtman N
    J Thorac Oncol; 2021 Jul; 16(7):1188-1199. PubMed ID: 33839364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.
    Cha YJ; Kim HR; Lee HJ; Cho BC; Shim HS
    Lung Cancer; 2016 Dec; 102():82-88. PubMed ID: 27987593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Qian ZR; Rubinson DA; Nowak JA; Morales-Oyarvide V; Dunne RF; Kozak MM; Welch MW; Brais LK; Da Silva A; Li T; Li W; Masuda A; Yang J; Shi Y; Gu M; Masugi Y; Bui J; Zellers CL; Yuan C; Babic A; Khalaf N; Aguirre A; Ng K; Miksad RA; Bullock AJ; Chang DT; Tseng JF; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar M; Wollison B; Laing A; Hahn WC; Meyerson M; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Wolpin BM
    JAMA Oncol; 2018 Mar; 4(3):e173420. PubMed ID: 29098284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3.
    Nakagomi T; Goto T; Hirotsu Y; Shikata D; Yokoyama Y; Higuchi R; Otake S; Amemiya K; Oyama T; Mochizuki H; Omata M
    Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30513627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
    Jurmeister P; Vollbrecht C; Behnke A; Frost N; Arnold A; Treue D; Rückert JC; Neudecker J; Schweizer L; Klauschen F; Horst D; Hummel M; Dietel M; von Laffert M
    Lung Cancer; 2019 Dec; 138():43-51. PubMed ID: 31634654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
    Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
    J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of a Prognostic Prediction Model of Patients with Pathologic N0 
in Resected Invasive Mucinous Adenocarcinoma of the Lung].
    Wang Z; He J; Shen H; Chen X; Lin C; Yu H; Gao J; He X; Shen W
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):47-55. PubMed ID: 38296625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
    Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W
    World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.